Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

Revenues for MEDPLUS are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 3.197000
forwardPE 38.091564
debtToEquity 64.360000
earningsGrowth 0.544000
revenueGrowth 0.013000
grossMargins 0.243710
operatingMargins 0.047800
trailingEps 12.540000
forwardEps 15.120000

MEDPLUS's current ratio, being 3.197, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, MEDPLUS is well-equipped to meet its immediate financial obligations without any difficulties.
MedPlus Health Services Limited's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that MedPlus Health Services Limited's financial performance will improve in the current financial year.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

MEDPLUS's price projections have gradually increased over time, indicating that analysts are becoming more optimistic about the company's prospects. This suggests confidence in MEDPLUS's ability to achieve future growth.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


A recent buy bias from analysts toward MEDPLUS may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that MEDPLUS might be an appealing option for those looking to grow their wealth through stock market investments.